Nebulizers
Market share is expected to hold a value of USD 1.27 Billion by 2030 and is
expected to register a growth of 6.90% from 2022 to 2030. Drug wastage is
one of the biggest challenges faced by the healthcare sector following device
usage. Sensing the opportunity, several companies are coming up with highly
innovative nebulizers such as vibrating mesh, breath-enhanced and
breath-actuated nebulizers that cut down drug wastage and enhance the
efficiency of drug delivery. Such nebulizers help elevate the output rate while
reducing the entire administration period. Besides, the heightened demand for
healthcare devices that can be used at home and the surging consumption of
cigarettes, alcohol and tobacco that cause respiratory disorders should also
enhance the market size in the years to come.
Most of the renowned vendors are focused on
promotion campaigns, mergers, collaborations, as well as product approvals, to
uplift their market positions. A case in point, in March 2021, PARI Pharma
GmbH, a reputed developer of aerosol delivery systems that are based on the
eFlow Technology, confirmed LAMIRA Nebulizer System’s authorization for
delivering Insmed's ARIKAYCE in the Japanese market.
Companies
Profiled
Braun Melsungen AG (Germany), Invacare
Corporation (US), Drive DeVilbiss Healthcare (US), Briggs Healthcare (US), GF
Health Products, Inc. (US), PARI (US), Agilent Technologies Inc. (US),
Koninklijke Philips N.V. (Netherlands), OMRON Healthcare (Japan), Vectura Group
PLC (UK), Beurer GmBH (Germany), Rossmax International Ltd (Taiwan), are the
prominent firms in the global market.
Segmental
Status
The nebulizers
market outlook has been dissected with respect to type, usage, portability
along with end user.
The nebulizer types that are available in
the global market are jet, ultrasonic as well as mesh. The types of mesh
nebulizers include passive and active. From the main types of nebulizers, the jet
nebulizers types should procure the top position over the following years since
they are far more cost-effective compared to other types in the market and
should therefore, note higher demand.
Usage-wise, the major segments can be reusable
and disposable. Out of these, the leading spot has been secured by disposable
nebulizers, as these witness significant demand given the provision of reduced
infection rate as well as wastage.
Portable and tabletop are identified as the
main segments, as per portability. The portable nebulizers market has been
progressing at the fastest pace, thanks to its convenient coupled with ease of
use.
Home care, along with hospitals &
clinics are the industry end-users covered in the MRFR study. In light of the
expanding patient base, hospitals and clinics have emerged as the leading
segment in the market. But, it is likely that the homecare segment will achieve
the fastest growth rate in the years ahead.
Regional
Status
Europe/EU, the Americas, Asia Pacific/APAC
and Middle East and Africa/MEA are the key regions across which the nebulizers
market is expected to note growth over the review period.
The American market has emerged the clear
winner out of the regions, on account of the alarming growth in respiratory
disorders and the favorable reimbursement schemes available in the region. The
region’s performance will be further bolstered by the fact that consumers here
follow a fast-moving lifestyle and therefore, opt for portable devices that are
compact and have multiple advanced features. This scenario is also favored by
the escalating cases of asthma and a number of airway diseases in the region.
The European market stands second and is
expected to attain higher growth in the coming years, in view of the fast-expanding
elderly patient base affected by several respiratory diseases. Frequent
technological advances and the emergence of new and more sophisticated
nebulizers in the market should be favorable as well.
The market size in Asia Pacific is expected
to grow at the fastest pace during the analysis period, largely due to the
rapidly surging cases of respiratory diseases, especially among the massive
geriatric populace. The soaring trend of preventive care, along with surge in
government initiatives to spread awareness among people while also encouraging
technological innovations will benefit the APAC industry over the years to
follow.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future (MRFR) expects the nebulizers
market trends to attain a valuation of USD 1,629.7 Million by the year
2027. It is also presumed that the market size will continue to soar at a rate
of 7.32% between 2020 and 2027.
Top
Boosters and Key Barriers
The COVID-19 outbreak has interestingly
been opportune for the nebulizers industry. The rising cases of SARS-CoV-2 have
pushed the demand for albuterol inhalers across hospitals for treating
suspected patients suffering from respiratory issues. COVID-19 is a common
facilitator of asthma or respiratory exacerbations, with the geriatric
population deemed to be more susceptible to these health conditions. This
demography is also highly prone to several respiratory conditions such as
Chronic Obstructive Pulmonary Disease (COPD), novel coronavirus as well as
sleep apnea. In a nutshell, the burgeoning elderly population should foster the
demand for nebulizers market in the upcoming years.
Drug wastage is one of the biggest
challenges faced by the healthcare sector following device usage. Sensing the
opportunity, several companies are coming up with highly innovative nebulizers
such as vibrating mesh, breath-enhanced and breath-actuated nebulizers that cut
down drug wastage and enhance the efficiency of drug delivery. Such nebulizers
help elevate the output rate while reducing the entire administration period.
Besides, the heightened demand for healthcare devices that can be used at home
and the surging consumption of cigarettes, alcohol and tobacco that cause
respiratory disorders should also enhance the market size in the years to come.
Companies
Profiled
Braun Melsungen AG (Germany), Invacare
Corporation (US), Drive DeVilbiss Healthcare (US), Briggs Healthcare (US), GF
Health Products, Inc. (US), PARI (US), Agilent Technologies Inc. (US),
Koninklijke Philips N.V. (Netherlands), OMRON Healthcare (Japan), Vectura Group
PLC (UK), Beurer GmBH (Germany), Rossmax International Ltd (Taiwan), are the
prominent firms in the global market.
Segmental
Status
The nebulizers industry has been dissected
with respect to type, usage, portability along with end user.
The nebulizer types that are available in
the global market are jet, ultrasonic as well as mesh. The types of mesh
nebulizers include passive and active. From the main types of nebulizers, the jet
nebulizers types should procure the top position over the following years since
they are far more cost-effective compared to other types in the market and
should therefore, note higher demand.
Usage-wise, the major segments can be
reusable and disposable. Out of these, the leading spot has been secured by
disposable nebulizers, as these witness significant demand given the provision
of reduced infection rate as well as wastage.
Portable and tabletop are identified as the
main segments, as per portability. The portable nebulizers market has been
progressing at the fastest pace, thanks to its convenient coupled with ease of
use.
Home care, along with hospitals &
clinics are the industry end-users covered in the MRFR study. In light of the
expanding patient base, hospitals and clinics have emerged as the leading
segment in the market. But, it is likely that the homecare segment will achieve
the fastest growth rate in the years ahead.
Regional
Status
Europe/EU, the Americas, Asia Pacific/APAC
and Middle East and Africa/MEA are the key regions across which the nebulizers
market report is expected to note growth over the review period.
The American market has emerged the clear
winner out of the regions, on account of the alarming growth in respiratory
disorders and the favorable reimbursement schemes available in the region. The
region’s performance will be further bolstered by the fact that consumers here
follow a fast-moving lifestyle and therefore, opt for portable devices that are
compact and have multiple advanced features. This scenario is also favored by
the escalating cases of asthma and a number of airway diseases in the region.
The European market stands second and is
expected to attain higher growth in the coming years, in view of the
fast-expanding elderly patient base affected by several respiratory diseases.
Frequent technological advances and the emergence of new and more sophisticated
nebulizers in the market should be favorable as well.
The market size in Asia Pacific is expected
to grow at the fastest pace during the analysis period, largely due to the
rapidly surging cases of respiratory diseases, especially among the massive
geriatric populace. The soaring trend of preventive care, along with surge in
government initiatives to spread awareness among people while also encouraging
technological innovations will benefit the APAC industry over the years to
follow.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Scope of the Report
Market Research Future (MRFR) expects the nebulizers market to attain a valuation of USD 1,629.7 Million by the year 2027. It is also presumed that the market size will continue to soar at a rate of 7.32% between 2020 and 2027.
Top Boosters and Key Barriers
The COVID-19 outbreak has interestingly been opportune for the nebulizers industry. The rising cases of SARS-CoV-2 have pushed the demand for albuterol inhalers across hospitals for treating suspected patients suffering from respiratory issues. COVID-19 is a common facilitator of asthma or respiratory exacerbations, with the geriatric population deemed to be more susceptible to these health conditions. This demography is also highly prone to several respiratory conditions such as Chronic Obstructive Pulmonary Disease (COPD), novel coronavirus as well as sleep apnea. In a nutshell, the burgeoning elderly population should foster the demand for nebulizers market in the upcoming years.
Drug wastage is one of the biggest challenges faced by the healthcare sector following device usage. Sensing the opportunity, several companies are coming up with highly innovative nebulizers such as vibrating mesh, breath-enhanced and breath-actuated nebulizers that cut down drug wastage and enhance the efficiency of drug delivery. Such nebulizers help elevate the output rate while reducing the entire administration period. Besides, the heightened demand for healthcare devices that can be used at home and the surging consumption of cigarettes, alcohol and tobacco that cause respiratory disorders should also enhance the market size in the years to come.
Companies Profiled
Braun Melsungen AG (Germany), Invacare Corporation (US), Drive DeVilbiss Healthcare (US), Briggs Healthcare (US), GF Health Products, Inc. (US), PARI (US), Agilent Technologies Inc. (US), Koninklijke Philips N.V. (Netherlands), OMRON Healthcare (Japan), Vectura Group PLC (UK), Beurer GmBH (Germany), Rossmax International Ltd (Taiwan), are the prominent firms in the global market.
Segmental Status
The nebulizers industry has been dissected with respect to type, usage, portability along with end user.
The nebulizer types that are available in the global market are jet, ultrasonic as well as mesh. The types of mesh nebulizers include passive and active. From the main types of nebulizers, the jet nebulizers types should procure the top position over the following years since they are far more cost-effective compared to other types in the market and should therefore, note higher demand.
Usage-wise, the major segments can be reusable and disposable. Out of these, the leading spot has been secured by disposable nebulizers, as these witness significant demand given the provision of reduced infection rate as well as wastage.
Portable and tabletop are identified as the main segments, as per portability. The portable nebulizers market has been progressing at the fastest pace, thanks to its convenient coupled with ease of use.
Home care, along with hospitals & clinics are the industry end-users covered in the MRFR study. In light of the expanding patient base, hospitals and clinics have emerged as the leading segment in the market. But, it is likely that the homecare segment will achieve the fastest growth rate in the years ahead.
Regional Status
Europe/EU, the Americas, Asia Pacific/APAC and Middle East and Africa/MEA are the key regions across which the nebulizers market is expected to note growth over the review period.
The American market has emerged the clear winner out of the regions, on account of the alarming growth in respiratory disorders and the favorable reimbursement schemes available in the region. The region’s performance will be further bolstered by the fact that consumers here follow a fast-moving lifestyle and therefore, opt for portable devices that are compact and have multiple advanced features. This scenario is also favored by the escalating cases of asthma and a number of airway diseases in the region.
The European market stands second and is expected to attain higher growth in the coming years, in view of the fast-expanding elderly patient base affected by several respiratory diseases. Frequent technological advances and the emergence of new and more sophisticated nebulizers in the market should be favorable as well.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.